Latest news
MRA Advisory Group Buys Shares of 23,652 Bristol Myers Squibb Company $BMY - MarketBeatMarketBeat · Sat, 08 Aug 2026 10:42:51 GMTAstraZeneca may buck a decade of pharma strategy to buy U.S. scale - CNBCCNBC · Thu, 06 Aug 2026 09:40:16 GMTRBC pours cold water: The likelihood of AstraZeneca (AZN.US) acquiring Bristol-Myers Squibb (BMY.US) is extremely low, with valuation differences and antitrust issues posing the biggest obstacles. - BitgetBitget · Tue, 04 Aug 2026 02:05:56 GMTAstraZeneca investors balk at prospect of $400 billion Bristol Myers pharma deal - ReutersReuters · Mon, 03 Aug 2026 18:43:06 GMTRBC pours cold water: AstraZeneca (AZN.US) acquiring Bristol Myers Squibb (BMY.US) is "highly unlikely", with valuation disagreements and antitrust issues being the biggest obstacles - BitgetBitget · Mon, 03 Aug 2026 17:41:02 GMTAn AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled. - BioPharma DiveBioPharma Dive · Mon, 03 Aug 2026 16:29:12 GMTPotential AstraZeneca purchase of Bristol-Myers unlikely for now - analyst - Seeking AlphaSeeking Alpha · Mon, 03 Aug 2026 16:21:53 GMTAstraZeneca-BMS $400bn merger could reshape US pharma manufacturing - Manufacturing ChemistManufacturing Chemist · Mon, 03 Aug 2026 12:37:56 GMT